TP53 and neoplasm: Mouse models of different hotspot mutp53 and clinical data from germline and sporadic cancers have clearly established that p53 missense mutations not only abolish the tumor suppressive function but may also acquire new tumorigenic driver activities, namely, gain-of-function (GOF) [10,11].